Cargando…

A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator

Cyclic oligoadenylate (cOA) secondary messengers are generated by type III CRISPR systems in response to viral infection. cOA allosterically activates the CRISPR ancillary ribonucleases Csx1/Csm6, which degrade RNA non-specifically using a HEPN (Higher Eukaryotes and Prokaryotes, Nucleotide binding)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Athukoralage, Januka S., Graham, Shirley, Grüschow, Sabine, Rouillon, Christophe, White, Malcolm F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599890/ https://www.ncbi.nlm.nih.gov/pubmed/31071326 http://dx.doi.org/10.1016/j.jmb.2019.04.041

Ejemplares similares

Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate
por: Athukoralage, Januka S, et al.
Publicado: (2018)

Control of cyclic oligoadenylate synthesis in a type III CRISPR system
por: Rouillon, Christophe, et al.
Publicado: (2018)

Cyclic oligoadenylate signalling mediates Mycobacterium tuberculosis CRISPR defence
por: Grüschow, Sabine, et al.
Publicado: (2019)

Tetramerisation of the CRISPR ring nuclease Crn3/Csx3 facilitates cyclic oligoadenylate cleavage
por: Athukoralage, Januka S, et al.
Publicado: (2020)

The dynamic interplay of host and viral enzymes in type III CRISPR-mediated cyclic nucleotide signalling
por: Athukoralage, Januka S, et al.
Publicado: (2020)

Cyclic oligoadenylate signaling and regulation by ring nucleases during type III CRISPR defense
por: Athukoralage, Januka S., et al.
Publicado: (2021)

Fuse to defuse: a self-limiting ribonuclease-ring nuclease fusion for type III CRISPR defence
por: Samolygo, Aleksei, et al.
Publicado: (2020)

Structural basis of cyclic oligoadenylate degradation by ancillary Type III CRISPR-Cas ring nucleases
por: Molina, Rafael, et al.
Publicado: (2021)

A viral ring nuclease anti-CRISPR subverts type III CRISPR immunity
por: Athukoralage, Januka S, et al.
Publicado: (2020)

Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate
por: McMahon, Stephen A., et al.
Publicado: (2020)

The CRISPR ancillary effector Can2 is a dual-specificity nuclease potentiating type III CRISPR defence
por: Zhu, Wenlong, et al.
Publicado: (2021)

Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6
por: Garcia-Doval, Carmela, et al.
Publicado: (2020)

The Cyclic Oligoadenylate Signaling Pathway of Type III CRISPR-Cas Systems
por: Huang, Fengtao, et al.
Publicado: (2021)

Antiviral type III CRISPR signalling via conjugation of ATP and SAM
por: Chi, Haotian, et al.
Publicado: (2023)

Specificity and sensitivity of an RNA targeting type III CRISPR complex coupled with a NucC endonuclease effector
por: Grüschow, Sabine, et al.
Publicado: (2021)

Prespacer processing and specific integration in a Type I-A CRISPR system
por: Rollie, Clare, et al.
Publicado: (2018)

Molecular basis of cyclic tetra-oligoadenylate processing by small standalone CRISPR-Cas ring nucleases
por: Molina, Rafael, et al.
Publicado: (2022)

Regulation of the RNA and DNA nuclease activities required for Pyrococcus furiosus Type III-B CRISPR–Cas immunity
por: Foster, Kawanda, et al.
Publicado: (2020)

Structural basis of cyclic oligoadenylate binding to the transcription factor Csa3 outlines cross talk between type III and type I CRISPR systems
por: Xia, Pengjun, et al.
Publicado: (2022)

Characterization of the equine 2'-5' oligoadenylate synthetase 1 (OAS1) and ribonuclease L (RNASEL) innate immunity genes
por: Rios, Jonathan J, et al.
Publicado: (2007)

Regulation of cyclic oligoadenylate synthesis by the Staphylococcus epidermidis Cas10-Csm complex
por: Nasef, Mohamed, et al.
Publicado: (2019)

A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding
por: Han, Wenyuan, et al.
Publicado: (2018)

Structure of the Saccharolobus solfataricus type III-D CRISPR effector
por: Cannone, Giuseppe, et al.
Publicado: (2023)

Structure of the CRISPR Interference Complex CSM Reveals Key Similarities with Cascade
por: Rouillon, Christophe, et al.
Publicado: (2013)

Multiple nucleic acid cleavage modes in divergent type III CRISPR systems
por: Zhang, Jing, et al.
Publicado: (2016)

Oligoadenylation of 3′ decay intermediates promotes cytoplasmic mRNA degradation in Drosophila cells
por: Harnisch, Christiane, et al.
Publicado: (2016)

Origin and development of oligoadenylate synthetase immune system
por: Hu, Jiaxiang, et al.
Publicado: (2018)

Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
por: Sokolowski, Richard D., et al.
Publicado: (2014)

SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation
por: Steens, Jurre A., et al.
Publicado: (2021)

STUDIES ON THE FUNCTION OF INTRACELLULAR RIBONUCLEASES : III. The Relationship of the Ribonuclease Activity of Rat Liver Microsomes to their Biological Activity
por: Roth, Jay S.
Publicado: (1960)

Uridylation prevents 3′ trimming of oligoadenylated mRNAs
por: Sement, François Michaël, et al.
Publicado: (2013)

Ribonuclease III mechanisms of double-stranded RNA cleavage
por: Nicholson, Allen W
Publicado: (2014)

Mechanism of Ribonuclease III Catalytic Regulation by Serine Phosphorylation
por: Gone, Swapna, et al.
Publicado: (2016)

RNA Degradation in Staphylococcus aureus: Diversity of Ribonucleases and Their Impact
por: Bonnin, Rémy A., et al.
Publicado: (2015)

Rotavirus NSP1 Subverts the Antiviral Oligoadenylate Synthetase-RNase L Pathway by Inducing RNase L Degradation
por: Dai, Jin, et al.
Publicado: (2022)

Structural and Hydrodynamic Characterization of Dimeric Human Oligoadenylate Synthetase 2
por: Koul, Amit, et al.
Publicado: (2020)

Structure and mechanism of the type I-G CRISPR effector
por: Shangguan, Qilin, et al.
Publicado: (2022)

2′‐5′ oligoadenylate synthetase 1 polymorphism is associated with prostate cancer
por: Mandal, Sanjay, et al.
Publicado: (2011)

Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases
por: Choi, Un Yung, et al.
Publicado: (2015)

Innate Resistance to Flavivirus Infections and the Functions of 2′-5′ Oligoadenylate Synthetases
por: Mashimo, T., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rr4i3ucdbqb0vne5bb36jpslnj